Patritumab Deruxtecan in Patients With Solid Tumor Harboring an NRG1 Fusion
Clinical trial NCT06383884 · RECRUITING
Trial details
- NCT number
- NCT06383884
- Sponsor
- Samsung Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-13
- Primary completion
- 2027-04-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.